Home  : :  About  : :  Affiliated ACO, LLC

Affiliated ACO, LLC

ACO Name and Location

Affiliated ACO, LLC (A3083)
101 Willmar Avenue SW
Willmar, MN 56201

ACO Primary Contact

Primary Contact Name Caryn McGeary
Primary Contact Phone Number 320-231-5000
Primary Contact Email Address Caryn.McGeary@carrishealth.com

Organizational Information

ACO participants:

ACO Participant in Joint Venture
(Enter Y or N)
Affiliated Community Medical Centers, PA N

ACO governing body:

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name / DBA, if Applicable
Title /
Smith Cindy Dr. Voting Member President, CEO Affiliated ACO, LL
Peterson Debra Dr. Voting Member CMO Affiliated ACO, LL
Gerberding Stephen Mr. Voting Member Administrator Affiliated ACO, LL
Rozendaal Thomas Mr. Voting Member Treasurer / Secretary Affiliated ACO, LL
Quinn Joan Ms. Voting Member Medicare Beneficiary Affiliated ACO, LL

Key ACO clinical and administrative leadership:

Stephen Gerberding ACO Executive
Dr. Debra Peterson Medical Director
Kelly Tauber Compliance Officer
Kelly Tauber Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Compliance Committee Kelly Tauber, Quality Manager
Finance Committee Thomas Rozendaal, Director of Finance
Operations Committee Stephan Gerberding, Administrator
Quality & Clinical Informatics Committee Caryn McGeary, Direcot of Patient Care
Utilization Review Committee Dr. David Ross, Medical Director of Patient Relations

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 75.24 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 92.23 92.63
ACO-3 CAHPS: Patients' Rating of Provider 91.62 91.93
ACO-4 CAHPS: Access to Specialists 82.35 83.52
ACO-5 CAHPS: Health Promotion and Education 56.8 60
ACO-6 CAHPS: Shared Decision Making 76.64 75.28
ACO-7 CAHPS: Health Status/Functional Status 75.35 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 21.68 27.52
ACO-8 Risk-Standardized, All Condition Readmission 14.46 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 17.12 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 52.36 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 76.31 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 59.66 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 10.53 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 17.7 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 100 82.72
ACO-39 Documentation of Current Medications in the Medical Record 88.31 87.54
ACO-13 Falls: Screening for Future Fall Risk 74.21 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 77.43 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 88.4 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 64.92 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.76 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 85.04 53.63
ACO-19 Colorectal Cancer Screening 84.06 61.52
ACO-20 Breast Cancer Screening 79.45 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 42.17 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 82.35 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 14.52 18.24
ACO-41 Diabetes: Eye Exam   67.74 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 75.81 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 88.54 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 96.08 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 85.81 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

For 2016 Quality Performance Results please visit: https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/2016-Shared-Savings-Program-SSP-Accountable-Care-O/3jk5-q6dr/data

Note: In the Quality Performance Results file(s) above, search for "Affiliated ACO, LLC" to view the quality performance results. This ACO can also be found by using the ACO ID A53560 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.